Controls and Functions

Slides:



Advertisements
Similar presentations
KINETICS -REACTION RATES
Advertisements

Linear Models. Functions n function - a relationship describing how a dependent variable changes with respect to an independent variable n dependent variable.
Pharmacokinetics & Pharmacodynamics of Controlled Release Systems Presented By: Govardhan.P Dept. of pharmaceutics, University College of Pharmaceutical.
One-compartment open model: Intravenous bolus administration
Laplace transformation
Practical Pharmacokinetics
Solving Systems of Equations and Inequalities
Solving Systems of Equations and Inequalities Section 3.1A-B Two variable linear equations Section 3.1C Matrices Resolution of linear systems Section 3.1D.
Copyright © 2000 by the McGraw-Hill Companies, Inc. Barnett/Ziegler/Byleen Precalculus: A Graphing Approach Chapter Eight Systems: Matrices.
Dosing Regimen Design Infusion regimen.
Gokaraju Rangaraju College of Pharmacy
INTRAVENOUS INFUSION.
Name: Angelica F. White WEMBA10. Teach students how to make sound decisions and recommendations that are based on reliable quantitative information During.
Nonlinear Pharmacokinetics
PLASMA HALF LIFE ( t 1/2 ).  Minimum Effective Concentration (MEC): The plasma drug concentration below which a patient’s response is too small for clinical.
PHARMACOKINETIC MODELS
3.1 Solving equations by Graphing System of equations Consistent vs. Inconsistent Independent vs. Dependent.
Multiple dosing: intravenous bolus administration
1 Single-dose kinetics Plasma [Drug] curve Upon administration [drug] plasma reaches a max Then begins to decline as the Drug is eliminated Cp max = max.
Grade Statistics without Bonus with Bonus Average = 86 Median = 87 Average = 88 Median = 89 Undergraduates Average=88 MS Average=92.
Continuous intravenous infusion (one-compartment model)
BIOPHARMACEUTICS.
Data Analysis, Presentation, and Statistics
Finding Answers. Steps of Sci Method 1.Purpose 2.Hypothesis 3.Experiment 4.Results 5.Conclusion.
Chapter 8 Systems of Linear Equations in Two Variables Section 8.3.
ــــــــــــــ February 17 th, PHT - LECTURE Mathematical Fundamental in Pharmacokinetics Dr. Ahmed Alalaiwe.
415 PHT Plasma Level – Time Curve
Pharmacokinetics 3rd Lecture
Source: Frank M. Balis Concentration and Effect vs. Time Conc./ Amount Effect [% of E MAX ] Time Central Compartment Peripheral Compartment Effect Compartment.
MULTIPLE DOSAGE REGIMEN
MS WinNonLin Project 9/28/15: PK Modeling I project due today.
Drug Response Relationships
Announcements Handouts on back tables
Write linear equations that represent direct variation
From: Long-Term Outcomes of Patients With Recent-Onset Rheumatoid Arthritis After 10 Years of Tight Controlled TreatmentA Randomized Trial Ann Intern Med.
Pharmacokinetics Tutoring
Lecture-8 Biopharmaceutics
Pharmacokinetic Modeling (describing what happens)
Determination of toxic doses from log normal and log logistic models
Solve Linear Systems by Graphing
Applications of Pharmacokinetics
Chapter 1 Introduction to Biopharmaceutics & Pharmacokinetics
Graphing Data.
The 3-compartment pharmacokinetic model
Anticonvulsants: Valproic acid
Module 1 Review ( ) Rewrite the following equations in slope-intercept form (solve for y), then graph on the coordinate plane.
Quantitative Pharmacokinetics
Pharmacokinetics.
Solving Systems of Linear Equations and Inequalities Graphically
Chapter 5: Systems of Linear Equations
Biopharmaceutics Dr Mohammad Issa Saleh.
5 Pharmacodynamics.
4.4 Analyzing Functions.
Integrated Rate Law Expresses the reactant concentrations as a function of time. aA → products Kinetics are first order in [A], and the rate law is Rate.
Clinical Pharmacokinetics
Calculate Breakeven Point in Units and Revenue Dollars
Bellringer. October 25, 2017 Worksheet. Turn in homework.
SCSH3. Students will identify and investigate problems scientifically
Lesson 3: Linear Relations
4.3B Analyzing Functions.
Introduction Previous lessons have demonstrated that the normal distribution provides a useful model for many situations in business and industry, as.
Absolute Value Functions
1 Concentration-time curve
Therapeutic Drug Monitoring chapter 1 part 1
Graphing data.
Graphs and Their Meaning
REFERENCE: APPLIED CLINICAL Slideshow by: lecturer HADEEL DELMAN
- COURSE DATA PRESENTATION.
A change in either volume of distribution or clearance has differing effects on the concentration-time profile. A change in either volume of distribution.
Presentation transcript:

Controls and Functions Kineticlass 6 Controls and Functions

Kineticlass navigation VMCVM students in “Normal Animal” ignore. PK glossary, equation help, AND this presentation. Hover for menu

Kineticlass modules A module consists of these sections: Objectives What the instructor hopes you will learn. Significance What does this mean for clinical patients (therapeutics) Exercise Steps you take to complete the module. Questions Self assessment (access to a key is provided)

Kineticlass exercises An exercise includes the following: Download (Excel worksheet) Target Concentrations Pharmacokinetic “end-points” for clinical effect generally expressed as some minimum and maximum concentration Will indicate why are these targets important. Manipulate Dosage Alter settings in the worksheet. Inspect Look at calculated values, steady-state concentrations and graphs. Assess A review of what was demonstrated. Consider effects on therapy

View of worksheet for module 1 (initial state) View of worksheet for module 1 (initial state). Kineticlass worksheets always show numeric data on the left and graphs on the right. Graphs may reflect a single (initial) dose or multiple doses.

Excel worksheets Variables Target concentrations Graph key (rows 1 and 2) User can set values in boxes – others locked Target concentrations Can be set to show various clinical targets. Minimum effective (MEC) and minimum toxic (MTC) for simulation 1.

Excel worksheets Calculated values Steady -state Values determined by Vz and Clt (ONLY) Steady -state These values depend on kinetics, dose, and dose interval. Assume repeated dosing Graphs will not reflect these values unless steady state is reached on the graph.

Linear graph (top) provides best visualization of relevant concentrations and times. (e.g. Time above MEC) Log graph (bottom) provides best visualization of elimination rate constant (slope) and model characteristics (one compartment in this case).

Simulations 1 and 2 overlap Module 1 – Linear plot (top) and semi-log plot (bottom) of initial conditions.

Dose for #2 and #4 (IV) are now double those of #1 and #3 (oral). Changing the dose does not affect Clt, Vz, Ka or F (model characteristics that are dose Independent). Target concentrations remain the same. Calculated values do not change. (Depend ONLY on Clt and Vz) Steady-state values are different #1 vs #2 and #3 vs $4. (Depend on Clt and Vz, dose and interval.)

Compare #1 to #2 Compare # 3 to #4 Compare #1 to #2 Compare # 3 to #4